The Iceland-based company said that a jury in the US District Court for the District of Delaware upheld the validity of Nox’s patent for biometric connectors it uses on its disposable RIP belts. The jury also awarded the company damages for infringement from Natus after finding that Natus willfully infringed upon one of Nox’s patents.
Nox touted the win as the third against Natus in relation to the RIP belt biometric connectors, and said that it will “continue its pursuit of justice” by seeking enhanced damages and attorney’s fees as a response to the willful infringement.
“This was an important and long-awaited victory for Nox Medical. We have been forced to battle this litigation for over two years because Nox Medical believes in its technology and in its intellectual property. Nox Medical was founded on innovation, and innovation continues to be Nox Medical’s distinguishing characteristic. Consequently, when Natus copied our invention Nox Medical was compelled to protect its intellectual property despite going against a much larger competitor with far more resources to dedicate to the litigation. Nonetheless, we had confidence that our patent would survive all Natus’ attacks, and that the jury would hold Natus accountable for willfully infringing the ‘532 patent. This victory is not only important for Nox Medical, but the entire industry as it fosters continued innovation in the whole field of sleep diagnostics. Respect for innovation and intellectual property is particularly important in the field of medical devices. As soon as one large company starts to infringe on the innovation of others in the field it will cause stagnation and will be detrimental to everyone in the field. We will continue to protect our intellectual property, not only with our own best interest at heart, but also to encourage others in the field to innovate and push boundaries,” Nox CEO Petur Halldorsson said in a press release.
Last month, Nox Medical said that the European Patent Office determined that its European patent for biometric connectors in its RIP belts were “valid as amended” in proceedings brought against it by Natus.
Early rates for DeviceTalks Boston end August 15th.
Don't miss the chance to save $100 and join top medtech innovators including leaders from Hologic, Google, Gray Matter, TransEnterix, NxStage Medical, Smith & Nephew, HeartFlow, Dynatronics, Johnson & Johnson, Allied Minds, and many more.
View Full Agenda
Register today to save. Use code LASTCALL to save an additional 10%.